We proudly announce that the National Accreditation Board for Hospitals & Healthcare Providers (NABH) which is a constituent board of the Quality Council of India (QCI) has accredited Dr. Mohan’s Diabetes Specialities Centre, Gopalapuram for the Entry – level requirements.
It has always been our endeavour to constantly improve the Quality standards. The National Accreditation Board for Hospitals and Healthcare Providers (NABH) conducted a rigorous assessment of the Organizational performance with reference to the NABH standards & the scope of services and certified Dr. Mohan’s Diabetes Specialities Centre, Gopalapuram.
This accreditation ensures excellence in Quality of care and patient safety. It also ensures that the patient satisfaction is regularly monitored and given utmost importance. Rights of patients are respected and protected. More focus is being provided clinical outcomes, medication management, medical records and infection control.
This accreditation also ensures that the patients are treated by well qualified and trained staff. It emphasises our commitment to prevent adverse events.
On the occasion of “The New Frontiers in Diabetes (NFD)” Conclave held at KLES Dr.Prabhakar Kore Hospital & Medical Research Centre, Belgaum (23rd Dec 2017), Dr.M.Balasubramanyam, Dean of Research Studies & Senior Scientist from the Madras Diabetes Research Foundation (MDRF), Chennai received the NFD Oration Award and spoke on: “Clinical Relevance and Utility of Omics Advancements in Diabetes”. His talk disseminated the following: New-Biology insights of diabetes pathogenesis with special reference to Omics advancements (genomics, proteomics, epigenetics, metabolomics, pharmacogenomics, metagenomics and exposomics); What it means to clinical diabetes setting and prevention strategies; Where do we stand now in terms of Biomarkers and Precision Medicine; The role of Artificial Intelligence (AI); Why lifestyle intervention matters; What are the road maps for the futurology of diabetes prevention, diagnosis, treatment and management.
Dr.M.Balasubramanyam (right) receiving the NFD Oration Award from Dr.M.V.Jali
Dr.M.Balasubramanyam, Dean of Research Studies & Senior Scientist from the Madras Diabetes Research Foundation, Chennai, India has been selected and named as ‘Australia Awards Ambassador’ by the Australian High Commission, New Delhi. On 3rd March 2017, Dr.Balasubramanyam received this prestigious award recognition from Ms. Harinder Sidhu, Australian High Commissioner to India, New Delhi. Dr.Balasubramanyam will spearhead and expose the Australia Awards/Scholarships opportunities that are awarded every year by the Australian Government to high-achieving students, researchers and professionals in India.
Dr Mohan’s Diabetes Specialities Centre was awarded the “OPPI Award for Improving Access to Diabetes Care” by the Organization of Pharmaceutical Producers of India (OPPI).
Dr. V. Mohan received the award from Dr. Jitendra Singh, Union Minister, Govt. of India at the 5th OPPI Healthcare Access Summit on Friday, August 19, 2016 at New Delhi.
Every year, the World Health Organisation observes April 7th as “World Health Day”, with a focus on a health-related theme of global importance. This year, the theme for World Health Day is “Beat Diabetes’, a slogan which assumes great significance for our centre in its 25th year of service. In consonance with its role as a WHO Collaborating Centre for Noncommunicable Disease, our centre conducted several activities on the occasion of World Health Day. These included quiz programs, healthy recipe demonstrations and diabetes screening camps at several locations including Chennai, Coimbatore, Bhubaneswar and Hyderabad. As a fitting culmination to the day’s activities, we also organized a Panel Discussion entitled “Prevention of Diabetes Needs a Multisectoral Approach” at Chennai.
Doctors are looking into poop samples to check if the bugs in the gut are putting Indians at greater risk for obesity, diabetes and cardiovascular diseases.
Scientists at the Madras Diabetes Research Foundation will sequence the DNA of bacteria in the bowel from the poop that people excreted and see if they have enough of good bacteria or too much of bad bacteria that can trigger metabolic diseases. The research centre has tied up with the University of Copenhagen for the research, which had earlier found strong links between gut bacteria and diabetes. At least 1.5kg of bacteria, living in the human bodies, mostly inside the gut, play an active role beyond digesting food. They are involved in the development and functioning of immune system, neuronal systems and a wide range of metabolic functions, doctors said. On Wednesday, the Danish scientists who spearheaded this research, Dr Oluf B Pedersen, professor of molecular metabolism and metabolic genetics from University of Copenhagen, Denmark, told reporters that the bacterial DNA extracted from stool samples from 292 individuals showed 23% of Danish adults had a 40% reduction in the abundance of bacterial genes.
The DNA sequence of bugs was kind of representation of what is going on in the colon. “We found people with fewer and less diverse bacteria had a higher body fat percentage and elevated blood lipids. This is a significant correlation. We want to know if results are similar in Indians,” said Pedersen. His Indian counterparts have sequenced DNA from bugs of more than 450 stool samples – an equal number of diabetics, pre-diabetes and healthy people. “As of now our hypothesis is that Indians are at greater risk because we have less of the good bacteria that reduce diabetes risk and more of bad bacteria that increases risk,” said diabetologist Dr V Mohan, who heads the research foundation.
There is no adequate evidence to show the link in humans, but stool samples from the lean twin mice given to germ-free mice, make them remain lean and stool from the obese mice and give it to germ-free mice make them obese. “So we can’t rule out that bacteria, in this case, may cause obesity. It may be more than just an innocent bystander,” said Dr Pederson. As of now scientists have no explanation about the exact role of bacteria, but they say evidence show that obese individuals in their colon have a bacterial community that is more efficient at saving energy and so poop out lesser bacteria.
Later during a scientific oration on the bugs in human life, he said looking at the bugs was like moving into a tropical rainforest – there are trillions of them living inside the human body in anaerobic (no oxygen) environment. That means they are difficult to culture in the lab and there can’t be a quick fix solution to refill these bacteria. However, the key to increasing abundance of good bacteria is in the diet.
A study from France showed that when obese people were put on an energy-restricted diet for six weeks, those who were low in bacterial genes, they tended to normalise their abundance of bacterial genes. “That said, I am sure in ten years, we will have enough information to come up with pills packed multi-bacteria from the gut that will prevent or slow down obesity, diabetes and heart diseases,” he said.
The Scientific Committee of Dr. Mohan’s Diabetes Specialties Centre and the Madras Diabetes Research Foundation, Chennai congratulates and salutes, Prof. Oluf Pedersen, Professor of Molecular Metabolism and Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark for his outstanding contributions in the fields of genomics and metagenomics of diabetes and has great pleasure in conferring the ‘25th DMDSC GOLD MEDAL ORATION AWARD’ on him. Dr. S. P. Thyagarajan, Professor of Eminence and Dean-Research, Sri Ramachandra Medical College, Porur, Chennai Presided and Presented the Gold Medal & Certificate to Prof. Oluf Perdersen on Wednesday, 2nd March, 2016.